Ontology highlight
ABSTRACT: Background
Previous data have demonstrated the clinical importance of vancomycin MIC values in Staphylococcus aureus bacteraemia (SAB); however, the impact of vancomycin tolerance (VT) is unknown.Objectives
To compare the frequency of clinical failure between patients with VT and non-VT isolates in SAB.Methods
This was a retrospective cohort study of patients with SAB, excluding treatment?<48?h or polymicrobial bacteraemia. The primary outcome was clinical failure (composite of 30?day mortality, non-resolving signs and symptoms, and 60?day recurrence). Vancomycin MIC and MBC were determined by broth microdilution. The association between VT (MBC/MIC??32) and clinical failure was evaluated by multivariable Poisson regression.Results
Of the 225 patients, 26.7% had VT isolates. VT was associated with clinical failure (48.0% overall) in unadjusted analysis [68.3% (n?=?41/60) versus 40.6% (n?=?67/165); P?ConclusionsVT was associated with clinical failure in SAB, irrespective of methicillin susceptibility or definitive treatment. VT may decrease the effectiveness of cell-wall-active therapy or be a surrogate marker of some other pathogen-specific factor associated with poor outcomes. Future research should evaluate if bactericidal non-cell-wall-active agents improve outcomes in VT SAB.
SUBMITTER: Britt NS
PROVIDER: S-EPMC6075607 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature
The Journal of antimicrobial chemotherapy 20161220 2
<h4>Background</h4>Previous data have demonstrated the clinical importance of vancomycin MIC values in Staphylococcus aureus bacteraemia (SAB); however, the impact of vancomycin tolerance (VT) is unknown.<h4>Objectives</h4>To compare the frequency of clinical failure between patients with VT and non-VT isolates in SAB.<h4>Methods</h4>This was a retrospective cohort study of patients with SAB, excluding treatment <48 h or polymicrobial bacteraemia. The primary outcome was clinical failure (compos ...[more]